ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

DRMA Company Profile and Key Details

NASDAQ : DRMA

Dermata Therapeutics, Inc.

$0.78

-0.0306-3.78%

At Close 4:00 PM

$0.73

−0.0440-5.65%

After-Market 08:30 PM

66.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

DRMA Stock Price Chart

Stock Price Today

Dermata Therapeutics, Inc. (DRMA) stock declined over -3.78%, trading at $0.78 on NASDAQ, down from the previous close of $0.81. The stock opened at $0.86, fluctuating between $0.72 and $0.97 in the recent session.

Stock Snapshot

0.8095

Prev. Close

0.86

Open

4.23M

Market Cap

5.43M

Number of Shares

0.721

Day Low

0.974

Day High

-0.1

P/E Ratio

73.47%

Free Float in %

-8.03

EPS (TTM)

1.62

Book Value

-1.63

Cash Flow per Share

2.06M

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	0.86	0.89	0.70	0.78	2.05M
Apr 14, 2025	0.80	0.82	0.79	0.81	38.89K
Apr 11, 2025	0.76	0.82	0.75	0.81	78.07K
Apr 10, 2025	0.80	0.82	0.72	0.79	99.8K
Apr 09, 2025	0.82	0.82	0.73	0.81	186.2K
Apr 08, 2025	0.88	0.92	0.81	0.84	366.05K
Apr 07, 2025	0.90	0.97	0.88	0.88	196.16K
Apr 04, 2025	0.92	0.97	0.88	0.96	173.91K
Apr 03, 2025	0.97	0.99	0.90	0.93	345.88K
Apr 02, 2025	0.95	1.08	0.95	0.99	551.81K
Apr 01, 2025	1.11	1.13	1.00	1.00	575.8K
Mar 31, 2025	1.09	1.19	1.05	1.08	555K
Mar 28, 2025	1.26	1.32	1.18	1.18	2.13M
Mar 27, 2025	2.20	2.37	1.35	1.42	76.33M
Mar 26, 2025	1.36	1.46	1.34	1.35	415.19K
Mar 25, 2025	1.30	1.40	1.25	1.35	219.42K
Mar 24, 2025	1.28	1.31	1.23	1.30	236.65K
Mar 21, 2025	1.16	1.24	1.16	1.24	144.81K
Mar 20, 2025	1.22	1.27	1.17	1.18	185.67K
Mar 19, 2025	1.18	1.28	1.16	1.22	198.4K

Contact Details

San Diego, CA 92130

United States

Website: https://www.dermatarx.comContact: 858 800 2543

About Company

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current Dermata Therapeutics, Inc. (DRMA) stock price?

Dermata Therapeutics, Inc. (NASDAQ: DRMA) stock price is $0.78 in the last trading session. During the trading session, DRMA stock reached the peak price of $0.97 while $0.72 was the lowest point it dropped to. The percentage change in DRMA stock occurred in the recent session was -3.78% while the dollar amount for the price change in DRMA stock was -$0.03.

DRMA's industry and sector of operation?

The NASDAQ listed DRMA is part of Biotechnology industry that operates in the broader Healthcare sector. Dermata Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of DRMA?

Mr. Gerald T. Proehl
Founder, Pres, Chief Executive Officer & Chairman
Ms. Kyri K. Van Hoose CPA, M.B.A.
Senior Vice President & Chief Financial Officer
Mr. Sean Proehl
Senior Director of Legal & Bus. Devel.
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. David F. Hale
Co-Founder & Lead Independent Director
Dr. Christopher J. Nardo M.P.H., Ph.D.
Senior Vice President & Chief Devel. Officer

How DRMA did perform over past 52-week?

DRMA's closing price is 11% higher than its 52-week low of $0.70 where as its distance from 52-week high of $6.17 is -87.37%.

How many employees does DRMA have?

Number of DRMA employees currently stands at 8.

Link for DRMA official website?

Official Website of DRMA is: https://www.dermatarx.com

How do I contact DRMA?

DRMA could be contacted at phone 858 800 2543 and can also be accessed through its website. DRMA operates from 3525 Del Mar Heights Road, San Diego, CA 92130, United States.

How many shares of DRMA are traded daily?

DRMA stock volume for the day was 2.06M shares. The average number of DRMA shares traded daily for last 3 months was 1.68M.

What is the market cap of DRMA currently?

The market value of DRMA currently stands at $4.23M with its latest stock price at $0.78 and 5.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	8
Beta	0.58
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology